Somatostatin receptor 5 and cannabinoid receptor 1 activation inhibit secretion of glucose-dependent insulinotropic polypeptide from intestinal K cells in rodents

Diabetologia

Volumn 55, Issue 11, 2012, Pages 3094-3103

  Moss, C E ^a   Marsh, W J ^a   Parker, H E ^a   Ogunnowo Bada, E ^a   Riches, C H ^a   Habib, A M ^a   Evans, M L ^a   Gribble, F M ^a   Reimann, F ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Cannabinoid receptor type 1; Glucagon like peptide 1; Glucose dependent insulinotropic polypeptide; K cells; Keywords Cannabinoid receptor; Somatostatin

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID 1 RECEPTOR; CYCLIC AMP; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; METHANANDAMIDE; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CNR1 GENE; CONTROLLED STUDY; GENE; GENE EXPRESSION; GLUCOSE TOLERANCE TEST; HORMONE BLOOD LEVEL; HORMONE RELEASE; INTESTINE CELL; KILLER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE; SSTR2 GENE; SSTR3 GENE; SSTR5 GENE;

ANIMALS; COLON; CYCLIC AMP; ENTEROENDOCRINE CELLS; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE 1; INCRETINS; INTESTINE, SMALL; MALE; MICE; MICE, INBRED C57BL; PRIMARY CELL CULTURE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTORS, SOMATOSTATIN; RNA, MESSENGER;

EID: 84867581999     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2663-5     Document Type: Article

References (37)

1. Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132:2131-2157
2. Miyawaki K, Yamada Y, Yano H et al (1999) Glucose intolerance caused by a defect in the entero-insular axis: A study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci U S A 96:14843-14847
3. Miyawaki K, Yamada Y, Ban N et al (2002) Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8:738-742
4. Irwin N, Flatt PR (2009) Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications. Diabetologia 52:1724-1731
5. AlthageMC, Ford EL,Wang S, Tso P, Polonsky KS,Wice BM(2008) Targeted ablation of glucose-dependent insulinotropic polypeptideproducing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet. J Biol Chem 283:18365-18376
6. Kieffer TJ (2003) GIP or not GIP? That is the question. Trends Pharmacol Sci 24:110-112
7. Buchan AM, Polak JM, Capella C, Solcia E, Pearse AG (1978) Electronimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) in man. Histochemistry 56:37-44
8. Buffa R, Polak JM, Pearse AG, Solcia E, Grimelius L, Capella C (1975) Identification of the intestinal cell storing gastric inhibitory peptide. Histochemistry 43:249-255
9. Diakogiannaki E, Gribble FM, Reimann F (2012) Nutrient detection by incretin hormone secreting cells. Physiol Behav 106:387-393
10. Gorboulev V, Schürmann A, Vallon V et al (2012) Na+-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 61:187-196
11. Parker HE, Habib AM, Rogers GJ, Gribble FM, Reimann F (2009) Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia 52:289-298
12. Hansen KB, Rosenkilde MM, Knop FK et al (2011) 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans. J Clin Endocrinol Metab 96:E1409-E1417
13. Parker HE, Reimann F, Gribble FM (2010) Molecular mechanisms underlying nutrient-stimulated incretin secretion. Expert Rev Mol Med 12:e1
14. Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ, Gribble FM (2008) Glucose sensing in L cells: A primary cell study. Cell Metab 8:532-539
15. Nikolaev VO, Bünemann M, Hein L, Hannawacker A, Lohse MJ (2004) Novel single chain cAMP sensors for receptor-induced signal propagation. J Biol Chem 279:37215-37218
16. Friedlander RS, Moss CE, Mace J et al (2011) Role of phosphodiesterase and adenylate cyclase isozymes in murine colonic glucagonlike peptide 1 secreting cells. Br J Pharmacol 163:261-271
17. Osundiji MA, Zhou L, Shaw J et al (2010) Brain glucosamine boosts protective glucoprivic feeding. Endocrinology 151:1499-1508
18. Järbe TU, Liu Q, Makriyannis A (2006) Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats. Psychopharmacology (Berl) 184:36-45
19. McLaughlin PJ, Winston K, Swezey L et al (2003) The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. Behav Pharmacol 14:583-588
20. Sprecher U, Mohr P, Martin RE et al (2010) Novel, non-peptidic somatostatin receptor subtype 5 antagonists improve glucose tolerance in rodents. Regul Pept 159:19-27
21. Kieffer TJ, Buchan AM, Barker H, Brown JC, Pederson RA (1994) Release of gastric inhibitory polypeptide from cultured canine endocrine cells. Am J Physiol 267:E489-E496
22. Chisholm C, Greenberg GR (2002) Somatostatin-28 regulates GLP-1 secretion via somatostatin receptor subtype 5 in rat intestinal cultures. Am J Physiol Endocrinol Metab 283:E311-E317
23. Mortensen K, Christensen LL, Holst JJ, Orskov C (2003) GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul Pept 114:189-196
24. Theodorakis MJ, Carlson O, Michopoulos S et al (2006) Human duodenal enteroendocrine cells: Source of both incretin peptides, GLP-1 and GIP. Am J Physiol Endocrinol Metab 290:E550-E559
25. Habib AM, Richards P, Cairns LS et al (2012) Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry. Endocrinology 153:3054-3065
26. O'Carroll AM, Raynor K, Lolait SJ, Reisine T (1994) Characterization of cloned human somatostatin receptor SSTR5. Mol Pharmacol 46:291-298
27. Izzo AA, Sharkey KA (2010) Cannabinoids and the gut: New developments and emerging concepts. Pharmacol Ther 126:21-38
28. Izzo AA, Piscitelli F, Capasso R et al (2009) Peripheral endocannabinoid dysregulation in obesity: Relation to intestinal motility and energy processing induced by food deprivation and refeeding. Br J Pharmacol 158:451-461
29. Petersen G, Sørensen C, Schmid PC et al (2006) Intestinal levels of anandamide and oleoylethanolamide in food-deprived rats are regulated through their precursors. Biochim Biophys Acta 1761:143-150, discussion 141-142
30. Gómez R, Navarro M, Ferrer B et al (2002) A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 22:9612-9617
31. Quarta C, Mazza R, Obici S, Pasquali R, Pagotto U (2011) Energy balance regulation by endocannabinoids at central and peripheral levels. Trends Mol Med 17:518-526
32. Butler H, Korbonits M (2009) Cannabinoids for clinicians: The rise and fall of the cannabinoid antagonists. Eur J Endocrinol 161:655-662
33. Pang Z, Wu NN, Zhao W et al (2011) The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice. Obesity (Silver Spring) 19:1923-1934
34. Yip RG, Boylan MO, Kieffer TJ, Wolfe MM (1998) Functional GIP receptors are present on adipocytes. Endocrinology 139:4004-4007
35. Hauner H, Glatting G, Kaminska D, Pfeiffer EF (1988) Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes. Ann Nutr Metab 32:282-288
36. McIntosh CH, Bremsak I, Lynn FC et al (1999) Glucosedependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3 T3-L1 cells: Wortmannin-sensitive inhibition by insulin. Endocrinology 140:398-404
37. AsmarM, Simonsen L,Madsbad S, Stallknecht B, Holst JJ, Bülow J (2010) Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans. Diabetes 59:2160-2163